The present disclosure provides methods treat or prevent a degenerative disc disease in a patient by administering to the patient a therapeutically effective amount of an advanced glycation endproduct (AGE) breaker. Methods for inhibiting the progression of a degenerative disc disease and for reducing the amount of an advanced glycation endproduct (AGE) in an intervertebral disc (IVD) are also provided.
